Can high-dose antioxidant supplements raise cancer risk?

Free radicals damage cells. Antioxidants neutralise free radicals. Cancer starts with cell damage. Therefore antioxidant supplements should prevent cancer.

NCI describes antioxidants as substances that interact with and neutralise free radicals, thus preventing them from causing damage. They come from dietary sources such as fruits and vegetables, and from supplements.

The logic was so clean that researchers went and tested it properly, in large randomised trials. That is where the story turns.

NCI reviewed nine randomised controlled trials of dietary antioxidant supplements, and gives this conclusion: these nine randomised controlled clinical trials did not provide evidence that dietary antioxidant supplements are beneficial in primary cancer prevention.

Two results deserve individual attention, because they went beyond disappointing.

Beta-carotene in smokers. The ATBC study, run in Finland, found increased incidence of lung cancer among those who took beta-carotene supplements. The people most at risk of lung cancer were the ones the supplement appeared to harm.

Vitamin E and selenium. The SELECT trial tested these in men and found no reduction in the incidence of prostate or other cancers. It also found more prostate cancer cases among those who took vitamin E alone.

Two of the best-designed prevention trials ever run found more cancer in the supplement groups, not less.

NCI offers one possible explanation. It puts it carefully. The lack of benefit may come down to how the antioxidants were taken. In a trial they are purified chemicals. In a meal they arrive inside food, which holds complex mixtures of antioxidants, vitamins and minerals. NCI treats this as an open research question. It is not a settled mechanism.

That fits a pattern seen across nutrition research. A nutrient looks protective when studied as part of a whole diet. It is isolated, concentrated and put in a capsule. The benefit vanishes. Sometimes something worse appears.

Food is not a delivery system for single molecules, and a pill is not a shortcut to a diet.

If you are having cancer treatment right now, this section is the one to take to your appointment.

NCI cautions that some studies found people who took antioxidant supplements during cancer therapy had worse outcomes, especially if they were smokers. Its guidance is that these supplements should be used with caution, and that people with cancer should inform their doctors about their use of any dietary supplement.

There is a plausible reason for concern here that treatment teams think about a lot: some cancer treatments work by damaging cells, and it is not obvious that flooding the body with something designed to block that kind of damage is helpful.

That is exactly why this decision belongs with your oncologist rather than with a shop assistant or a search result.

• Make a list of everything you take, including doses, and bring it in. Photographs of the labels work fine.
• Do not stop a supplement your team has actually prescribed, such as one correcting a measured deficiency, without asking.
• Be especially careful with high-dose single nutrients, which is what these trials tested.
• Remember that fruit and vegetables carry no such warning. NCI's concerns attach to supplements.

The supplement aisle sells certainty, and cancer strips certainty away. Buying something feels like taking action at a moment when very little is under your control.

The trials above are the reason to pause. They were run in good faith by people who expected a benefit, and they found the opposite. That is science working correctly, and it is far more useful to you than a label promising immune support.

Ask your team before adding anything. It is a two-minute conversation that occasionally changes a treatment plan.